NCT04920032 2026-04-13Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon AdenocarcinomasUniversity of California, IrvinePhase 1 Recruiting22 enrolled
NCT04511039 2026-03-02Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal CancerRoswell Park Cancer InstitutePhase 1 Recruiting45 enrolled